Those infected with COVID-19 can now report potentially infected people
10.9.2021 13:45:29 EEST | HUS | Press release
A text message is sent to anyone who has received a positive COVID-19 test result. The message includes instructions to report any exposed persons in the MyCovidData.fi service. The service is used in the HUS area in all municipalities except Helsinki. Helsinki has its own system for reporting exposures.
‘The information provided in the service is useful preliminary information for infection tracers and speeds up the traceability process. The service can be used to report any locations the infected person has visited, and to write the names and telephone numbers of the people who have been exposed, as well as any other information related to the exposure’, says Deputy Chief Physician Eeva Ruotsalainen.
When the data is registered before an infection tracer calls, the data can be reviewed together and supplemented as necessary. The infection tracer confirms the exposures.
Using the service requires strong identification with online banking credentials or a mobile certificate. It is also possible to use the service on behalf of another person.
The service is now available in Finnish. Swedish and English versions of the service will soon be opened. In addition to municipalities in the HUS area, the service can be introduced in the areas of Kymote, Eksote and Northern Ostrobothnia Hospital Districts.
The address of the service is MyCovidData.fi.
Keywords
About HUS
At HUS Helsinki University Hospital about 680 000 patients receive medical care annually. We have almost 27,000 professionals working for the best of all patients. We are responsible for providing specialized health care for the residents of our 24 member municipalities. In addition, the treatment of many rare and severe diseases is nationally centralized to HUS.
HUS is the biggest health care provider and the second largest employer in Finland. Our expertise is internationally recognized and accredited. As a university hospital, we continuously develop and evaluate our treatment methods and activities.
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
HUS sammanslutningens styrelse behandlade förslaget till budgetram för 202720.4.2026 12:02:40 EEST | Pressmeddelande
HUS-sammanslutningens styrelse behandlade den fasta budgetram som ingår i förslaget till budget för 2027 samt verksamheten och ekonomin för januari–februari 2026.
HUSin yhtymähallitus käsitteli vuoden 2027 talousarvion kehysesitystä20.4.2026 12:02:40 EEST | Tiedote
HUSin yhtymähallitus käsitteli vuoden 2027 talousarvioesitykseen sisältyvää kiinteää talousarviokehystä sekä tammi-helmikuun 2026 toimintaa ja taloutta.
Behandling för ADHD kan ges redan före diagnosen20.4.2026 10:37:37 EEST | Pressmeddelande
Nätterapi för ADHD är avsedd för alla personer från 16 år och uppåt vars funktionsförmåga hotas av ADHD-liknande symtom. Den avgiftsfria nätterapin kan inledas snabbt och syftar till att lindra de besvär som symtomen orsakar samt förbättra funktionsförmågan.
ADHD:n hoitoa voi saada jo ennen diagnoosia20.4.2026 10:37:37 EEST | Tiedote
ADHD:n nettiterapia on tarkoitettu kaikille 16 vuotta täyttäneille, joiden toimintakykyä uhkaavat ADHD-tyyppiset oireet. Maksuttoman nettiterapian pääsee aloittamaan nopeasti, ja sen tavoitteena on lievittää oireiden aiheuttamaa haittaa ja parantaa toimintakykyä.
HUS-sammanslutningens styrelse sammanträder den 20 april 202616.4.2026 15:10:51 EEST | Pressmeddelande
HUS-sammanslutningens styrelse sammanträder måndagen den 20 april 2026 för att behandla bland annat förslaget till budget för 2027 samt verksamheten och ekonomin för januari–februari 2026. Föredragningslistan för mötet finns här. HUS medietjänst betjänar medier måndag–torsdag kl. 10–16, fredag kl. 10–15 på numret 050 427 2875 eller per e-post på viestinta@hus.fi. Se avvikande öppettider.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
